| Name | Title | Contact Details |
|---|
Infinite Group provides information technology consulting and integration services to government and commercial clients primarily in the United States.
Redbot Security is an expert provider of vendor neutral information and data security assessments as well as advisory services for Fortune 500 clients. The Redbot Security difference is our ability to deliver detailed insight into quantifiable risk. Redbot Security understands that information security comes from the proper mix of people, process and technology and must be tailored to each specific customer. Our expertise in penetration techniques and strong knowledge in evolving security trends enables us to effectively identify vulnerabilities in even the most complex systems. Redbot Security provides industry leading manual penetration testing. Our team of CISSP Senior Level Engineers are fully certified ethical hackers. We specialize in controlled, manual exploitation of Wireless, Internal, External, App, ICS/SCADA Penetration Testing and provide the industry`s best customer experience, scoping and service delivery.
IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company`s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user`s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.
TRIAXIA PARTNERS is a Atlanta, GA-based company in the Computers and Electronics sector.